Distinguished Software Architect
Edwards Lifesciences
Distinguished Software Architect
Edwards Lifesciences
Develops transcatheter heart valves and devices
Innovation starts from the heart. Our Advanced Innovation & Technology (AI&T) teams harness the imagination, courage, and resourcefulness to think beyond what’s currently possible, and create solutions for patients many years into the future. If you’re an early-stage innovator, then Edwards AI&T team is the place for you to take the next steps in your career. We’ll give you the tools and resources you need to create groundbreaking innovations that shape the future of structural heart technology.
How you will make an impact:
As the Distinguished Software Architect on the AI&T R&D Digital Product team, you will design and deliver scalable, secure, AI-enabled and cloud-enabled software solutions for regulated medical-device products, while driving architectural strategy, leveraging Generative AI to accelerate software development, and mentoring teams in a complex, highly regulated environment.
This is a fully on-site role based at our corporate headquarters in Irvine, CA.
What you'll need (Required):
What else we look for (Preferred):
Aligning our overall business objectives with performance, we offer competitive salaries, performance-based incentives, and a wide variety of benefits programs to address the diverse individual needs of our employees and their families.
For California, the base pay range for this position is $159,000 - $226,000 (highly experienced).
The pay for the successful candidate will depend on various factors (e.g., qualifications, education, prior experience). Applications will be accepted while this position is posted on our Careers website.
Edwards is an Equal Opportunity/Affirmative Action employer including protected Veterans and individuals with disabilities.
Develops transcatheter heart valves and devices
Edwards Lifesciences focuses on cardiovascular medical technologies, especially transcatheter heart valves. Its products enable repairing or replacing diseased heart valves through minimally invasive procedures rather than open-heart surgery. The company builds on a long history that began with the Starr-Edwards valve and now centers on valve therapies and related diagnostics to treat heart disease. It differentiates itself by specializing in valve technologies and transcatheter approaches, backed by a track record of clinical leadership and global reach. The goal is to improve patient outcomes by providing safer, less invasive valve treatment options for people around the world.
Explore more opportunities at Edwards Lifesciences